Development and technology-transfer enquiries
A development or transfer enquiry to GALVANTA COMPANY LIMITED should identify the proposed work, the information already held and the organisations responsible for the relevant processes.
Formulation questions
Identify the substance, intended form and question for discussion.
Process development
Identify the activity and documentary evidence sought, distinguishing the proposed process from a process already supported by studies or validation.
Scale-up
State the development and proposed production context, the process-specific information available and the evidence needed to assess production capacity or successful transfer.
Technology transfer
Identify the information owner, sending and receiving organisations, proposed responsibilities and any restrictions on disclosure.
Container compatibility
Specify the pharmaceutical presentation, proposed container and relevant compatibility and stability evidence beyond packaging artwork.
Coordination and records
Identify the deliverables, responsibilities, decision points and applicable authorisations for the proposed scope.
Contact
Email [email protected] with your organisation, jurisdiction and enquiry subject. Do not submit confidential compositions or proprietary development files through an initial enquiry. Arrange a suitable channel before exchanging protected technical information.
Prerequisites
The company holds no pharmaceutical manufacturing licence or GMP certificate. Any undertaking requires evidenced capability, applicable authorisations and a separate agreement. Development laboratories and manufacturing equipment require separate operational evidence. Intellectual-property rights, technical capability and regulatory responsibility require separate assessment from a transfer of documents.